about
Targeted nanotechnologies for cancer intervention: a patent review (2010-2016).Strategic Incorporation of Fluorine into Taxoid Anticancer Agents for Medicinal Chemistry and Chemical Biology Studies.Synthesis and biological evaluation of novel A-seco-taxoids derived from 1-deoxybaccatin VI.Ipilimumab for the treatment of metastatic prostate cancer.THANATOS: an integrative data resource of proteins and post-translational modifications in the regulation of autophagy.The effects of taxanes, vorinostat and doxorubicin on growth and proliferation of Echinococcus multilocularis metacestodes assessed with magnetic resonance imaging and simultaneous positron emission tomography.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Taxane anticancer agents: a patent perspective.
@en
Taxane anticancer agents: a patent perspective.
@nl
type
label
Taxane anticancer agents: a patent perspective.
@en
Taxane anticancer agents: a patent perspective.
@nl
prefLabel
Taxane anticancer agents: a patent perspective.
@en
Taxane anticancer agents: a patent perspective.
@nl
P2093
P2860
P1476
Taxane anticancer agents: a patent perspective.
@en
P2093
Brendan Lichtenthal
Changwei Wang
Siyeon Lee
P2860
P356
10.1517/13543776.2016.1111872
P407
P50
P577
2015-12-10T00:00:00Z